Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management.

A new single-dose autoinjector presentation of Adbry ® (tralokinumab-ldrm) is now available for use in the treatment of moderate to severe atopic dermatitis not adequately controlled with topical ...

HealthDay News — Most nicotine brand Instagram posts do not adhere to US Food and Drug Administration (FDA) health warning requirements for tobacco promotions, according to a study published online ...

In a disclosure that can't eliminate the possibility that bird flu may have spread from one human to another for the first time, US health officials have reported that a person who lived with a ...